Stockwaun, pumpers, everyone gone. Sold everything to bagholders.Once news comes out of EMA approval/denial, stock goes straight down. Little income to be gained in this indication in Europe as European doctors are not interested in prescribing a drug that was rejected by the FDA because it failed trials. Smarten up and sell this crap. Don't be a bagholder. And don't say I didn't warn you.
here we go again with your moronic comments, absolutely clueless , FDA convened an advisory panel to discuss the drug rather than just reject the application for a new use, struggling with simply rejecting a drug that potentially treats a serious unmet need. AML represents a disease with limited treatment options and Dacogen already being prescribed by some doctors to treat AML even though the drug isn’t approved for that use. It will be prescribed by every single doctor in EU!